Rhabdomyolisis with HMG CoA reductase inhibitors: a class effect?

Nigel Langford, Martin Kendall

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish
Title of host publicationJournal of Clinical Pharmacy and Therapeutics
Volume26
Publication statusPublished - 1 Jan 2001

Cite this